ROCKVILLE, Md., Dec. 11, 2015 (GLOBE NEWSWIRE) -- The Regulatory Affairs Professionals Society (RAPS) announced today the retirement of its Executive Director Sherry Keramidas whose leadership during a 20-year tenure helped advance the healthcare regulatory profession. She will retire on 31 January 2016.
"Sherry has served RAPS and its members during a critical period of change in the healthcare industry," according to RAPS Chairman of the Board Rainer Voelksen. "Her constancy throughout ensured RAPS' mission to provide leading education and professional development opportunities and credentialing to regulatory professionals. The RAPS Board of Directors extends its deepest appreciation to Sherry for her two decades of stewardship and commitment to RAPS members, partners and Board."
"It's been my pleasure to serve RAPS during a period of unprecedented change in the healthcare industry," said Keramidas. "The regulatory environment will continue to rapidly evolve and I retire from RAPS confident that the advancement of its professionals will continue to be the defining commitment of this organization's leadership."
The Board's top priority during the transition to new leadership is to ensure RAPS' continuity in fulfilling day-to-day operations that deliver on the organization's commitment to programming and other essential functions that serve its members and partners. Sherry will help facilitate the transition by working with the Executive Committee of the Board to provide support on specific key initiatives.
The Board has initiated a search for a new executive director and will be announcing a plan for interim leadership in the coming weeks. It has established a Search Committee of the Board and will engage a professional recruiting firm to conduct the search for the permanent executive director.
With questions or for more information, please contact RAPS President Martha A. Brumfield at [email protected].
About RAPS
The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization. RAPS offers education and training, professional standards, publications, research, knowledge sharing, networking, career development opportunities and other valuable resources, including Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence. RAPS is headquartered in suburban Washington, DC, with offices in Shanghai and Singapore, and chapters and affiliates worldwide. RAPS.org
CONTACT: Zachary Brousseau
Senior Manager, Communications
RAPS
+1 301 770 2920, ext. 245; [email protected]


Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Washington Post Publisher Will Lewis Steps Down After Layoffs
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Instagram Outage Disrupts Thousands of U.S. Users
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 



